Many of our patients in cardiac and pulmonary rehab are using cannabis products for medical or “recreational” purposes, and in many jurisdictions, sales have been legalized for months to years. As health professionals, our awareness about the pharmacology and clinical effects of cannabis may be lagging behind the widespread use of these products. This webinar will present a review of current literature and share some clinical observations in a case based format to enable more informed discussions and thoughtful assessments about cannabis use in our rehab settings.
Presented by: Paul Oh, MD, MSc, FRCPC, FACP
Disclosures: No relevant disclosures
Many of our patients in cardiac and pulmonary rehab are using cannabis products for medical or “recreational” purposes, and in many jurisdictions, sales have been legalized for months to years. As health professionals, our awareness about the pharmacology and clinical effects of cannabis may be lagging behind the widespread use of these products. This webinar will present a review of current literature and share some clinical observations in a case based format to enable more informed discussions and thoughtful assessments about cannabis use in our rehab settings.
Learning Objectives
1. Describe the pharmacology of cannabis and the different effects of THC and CBD
2. Evaluate the medical evidence for or against potential uses of cannabis by rehab clients
3. Be aware of the adverse effects of cannabis (THC) on the cardiovascular system
4. Update on the particular risk of vaping and lung injury
| Title | Credit(s) | |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| 4 |